Vertex Pharmaceuticals Inc (VRTX) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

Closelooknet score: 55 out of 100 (momentum 82 · quality 83 · valuation 23), as of 2026-11-11.
Signal: Trending — Above its 20-, 50- and 200-day — still in an uptrend. (as of 2026-11-09)
Trend: Vertex Pharmaceuticals Inc trades 5.3% above its 50-day and 14.3% above its 200-day moving average. (as of 2026-11-09)
Index seat: HALO Growth 100

Vertex Pharmaceuticals is a biotechnology company that sells drugs for cystic fibrosis, a lung and digestive disease caused by a faulty gene, including its main products Trikafta and Kaftrio. It also markets Casgevy, a gene-edited therapy for sickle cell disease and transfusion-dependent beta thalassemia, and Journavx for acute pain.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the VRTX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Trending

Above its 20-, 50- and 200-day — still in an uptrend.

The moving-average stack

vs 20-day+4.6%
vs 50-day+5.3%
vs 200-day+14.3%
52-week band3.1% off the high · +37.5% off the low
Streak2 consecutive up sessions
Stochastic%K 66.1 · %D 64.5 · up cross

Continue: the VRTX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on VRTX?

Trending — Above its 20-, 50- and 200-day — still in an uptrend. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is VRTX above its 50-day and 200-day moving averages?

As of 2026-11-09, Vertex Pharmaceuticals Inc trades +5.3% above its 50-day and +14.3% above its 200-day average, with the 20-day +4.6% away.

How far is VRTX from its 52-week high?

3.1% below the 52-week high and 37.5% above the 52-week low, as of 2026-11-09.

Mentioned on Closelooknet

Where VRTX appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000Midday 10 · 21 Aug 2026Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.